Formulating an ethical and potent vaccine against novel pathogens typically takes years. Globally, scientists, pharmaceutical firms, and regulators are arduously working to answer the most palpable question – a COVID-19 vaccine. While clinical trials are underway, it’s important to note that less than 10% of drugs get approved by the FDA. Players who make it past this have health safety and efficacy proofs, manufacturing scalability, and a host of other hurdles to navigate. With the ideal vaccine discovery timeline earmarked at 12-18 months, this infographic offers a bird’s eye view of the chase.
Download it to know the leading pharma players, their phase-wise deployments, challenges along with a realistic perspective on the much-awaited vaccine of our times.
